As a pharmacist-health services researcher, Dr. Antoinette Coe studies how to improve medication use and safety. Some of her motivation comes from personal experiences as a caregiver and helping famil ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...